1887

Chapter 39 : Evolution of Neisseria and Neisseria Infections

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Evolution of Neisseria and Neisseria Infections, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815639/9781555814144_Chap39-1.gif /docserver/preview/fulltext/10.1128/9781555815639/9781555814144_Chap39-2.gif

Abstract:

The N. meningitidis portal of entry is the nasopharynx. Asymptomatic carriage is the most frequent outcome of bacterial colonization, with transmission from host to host occurring through airborne salivary droplets. Secondary localization may occur if the bacteria crosses body barriers such as the blood-brain barrier to infect the subarachnoidal space, leading to meningitis, the most frequent meningococcal disease. As with other bacterial species, Neisseria undergo asexual haploid reproduction, although the frequent DNA transformation and recombination that occur between Neisseria species are responsible for localized gene exchanges. The development of this "sexual behavior" may be the result of the coevolution of pathogenic Neisseria as an obligate parasite of humans. The critical step in the development of pathogenic Neisseria infection takes place at the surface of epithelial cells. Pathogenic Neisseria strains usually release outer membrane vesicles (blebs) that contain large amounts of surface bacterial components. Contact between pathogenic Neisseria strains and viable target cells promotes the effective adhesion process through type IV pili, filamentous structures at the bacterial surface, crossing the N. meningitidis capsule. Iron acquisition on mucosal surfaces and in blood is crucial for neisserial virulence. The continuous shuffling and recombination of genes instead of the appearance of mutations are major traits in neisserial evolution. Evolution by tinkering should lead to genomic plasticity and the differential use of the same genes.

Citation: Taha M. 2008. Evolution of Neisseria and Neisseria Infections, p 465-474. In Baquero F, Nombela C, Cassell G, Gutiérrez-Fuentes J (ed), Evolutionary Biology of Bacterial and Fungal Pathogens. ASM Press, Washington, DC. doi: 10.1128/9781555815639.ch39
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1.
Figure 1.

Electron micrographs and representations of neisserial surface structures involved in the informative talk between bacteria and target cells.

Citation: Taha M. 2008. Evolution of Neisseria and Neisseria Infections, p 465-474. In Baquero F, Nombela C, Cassell G, Gutiérrez-Fuentes J (ed), Evolutionary Biology of Bacterial and Fungal Pathogens. ASM Press, Washington, DC. doi: 10.1128/9781555815639.ch39
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2.
Figure 2.

Interaction between N. meningitidis and epithelial target cells starts by the initial adhesion mediated by type IV pili. Subsequently, the bacteria interact intimately with the cellular membrane and the microvilli disappear. Bacteria can be observed inside the target cell.

Citation: Taha M. 2008. Evolution of Neisseria and Neisseria Infections, p 465-474. In Baquero F, Nombela C, Cassell G, Gutiérrez-Fuentes J (ed), Evolutionary Biology of Bacterial and Fungal Pathogens. ASM Press, Washington, DC. doi: 10.1128/9781555815639.ch39
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815639.ch39
1. Achtman, M.,, A. van der Ende,, P. Zhu,, I. S. Koroleva,, B. Kusecek,, G. Morelli,, I. G. Schuurman,, N. Brieske,, K. Zurth,, N. N. Kostyukova, and, A. E. Platonov. 2001. Molecular epidemiology of serogroup a meningitis in Moscow, 1969 to 1997. Emerg. Infect. Dis. 7:420427.
2. Achtman, M. 1994. Clonal spread of serogroup A meningococci: a paradigm for the analysis of microevolution in bacteria. Mol. Microbiol. 11:1522.
3. Achtman, M. 1997. Microevolution and epidemic spread of serogroup A Neisseria meningitidis—a review. Gene 192:135140.
4. Alber, D.,, M. Oberkotter,, S. Suerbaum,, H. Claus,, M. Frosch, and, U. Vogel. 2001. Genetic diversity of Neisseria lactamica strains from epidemiologically defined carriers. J. Clin. Microbiol. 39:17101715.
5. Alonso, J. M.,, A. Guiyoule,, M. L. Zarantonelli,, F. Ramisse,, R. Pires,, A. Antignac,, A. E. Deghmane,, M. Huerre,, S. van der Werf, and, M. K. Taha. 2003. A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice. FEMS Microbiol. Lett. 222:99106.
6. Bjune, G.,, E. A. Hoiby,, J. K. Gronnesby,, O. Arnesen,, J. H. Fredriksen,, A. Halstensen,, E. Holten,, A. K. Lindbak,, H. Nokleby,, E. Rosenqvist, et al. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:10931096.
7. Black, C. G.,, J. A. Fyfe, and, J. K. Davies. 1998. Absence of an SOS-like system in Neisseria gonorrhoeae. Gene 208:6166.
8. Boel, G.,, I. Mijakovic,, A. Maze,, S. Poncet,, M. K. Taha,, M. Larribe,, E. Darbon,, A. Khemiri,, A. Galinier, and, J. Deutscher. 2003. Transcription regulators potentially controlled by HPr kinase/phosphorylase in gram-negative bacteria. J. Mol. Microbiol. Biotechnol. 5:206215.
9. Camacho, J. P.,, M. Bakkali,, J. M. Corral,, J. Cabrero,, M. D. Lopez-Leon,, I. Aranda,, A. Martin-Alganza, and, F. Perfectti. 2002. Host recombination is dependent on the degree of parasitism. Proc. Biol. Sci. 269:21732177.
10. Cartwright, K. A.,, J. M. Stuart,, D. M. Jones, and, N. D. Noah. 1987. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol. Infect. 99:591601.
11. Chamaillard, M.,, S. E. Girardin,, J. Viala, and, D. J. Philpott. 2003. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell. Microbiol. 5:581592.
12. Deghmane, A. E.,, D. Giorgini,, M. Larribe,, J. M. Alonso, and, M. K. Taha. 2002. Down-regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein. Mol. Microbiol. 43:15551564.
13. Deghmane, A. E.,, M. Larribe,, D. Giorgini,, D. Sabino, and, M. K. Taha. 2003. Differential expression of genes that harbor a common regulatory element in Neisseria meningitidis upon contact with target cells. Infect. Immun. 71:28972901.
14. Deghmane, A. E.,, S. Petit,, A. Topilko,, Y. Pereira,, D. Giorgini,, M. Larribe, and, M. K. Taha. 2000. Intimate adhesion of Neisseria meningitidis to human epithelial cells is under the control of the crgA gene, a novel LysR-type transcriptional regulator. EMBO J. 19:10681078.
15. Dehio, C.,, S. D. Gray-Owen, and, T. F. Meyer. 1998. The role of neisserial Opa proteins in interactions with host cells. Trends Microbiol. 6:489495.
16. Devoe, I. W., and, J. E. Gilchrist. 1973. Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J. Exp. Med. 138:11561167.
17. Domingo, P.,, E. Muniz-Diaz,, M. A. Baraldes,, M. Arilla,, N. Barquet,, R. Pericas,, C. Juarez,, P. Madoz, and, G. Vazquez. 2002. Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. Am. J. Med. 112:1925.
18. Duboule, D., and, A. S. Wilkins. 1998. The evolution of ‘bricolage.’ Trends Genet. 14:5459.
19. Dunn, K. L.,, M. Virji, and, E. R. Moxon. 1995. Investigations into the molecular basis of meningococcal toxicity for human endothelial and epithelial cells: the synergistic effect of LPS and pili. Microb. Pathog. 18:8196.
20. Faust, S. N.,, M. Levin,, O. B. Harrison,, R. D. Goldin,, M. S. Lockhart,, S. Kondaveeti,, Z. Laszik,, C. T. Esmon, and, R. S. Heyderman. 2001. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N. Engl. J. Med. 345:408416.
21. Feil, E. J.,, Maiden, M. C.,, M. Achtman, and, B. G. Spratt. 1999. The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis. Mol. Biol. Evol. 16:14961502.
22. Figueroa, J.,, J. Andreoni, and, P. Densen. 1993. Complement deficiency states and meningococcal disease. Immunol. Res. 12:295311.
23. Figueroa, J. E., and, P. Densen. 1991. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4:359395.
24. Gill, D. B.,, D. Spitzer,, M. Koomey,, J. E. Heuser, and, J. P. Atkinson. 2005. Release of host-derived membrane vesicles following pilus-mediated adhesion of Neisseria gonorrhoeae. Cell. Microbiol. 7:16721683.
25. Girardin, S. E.,, I. G. Boneca,, L. A. Carneiro,, A. Antignac,, M. Jehanno,, J. Viala,, K. Tedin,, M. K. Taha,, A. Labigne,, U. Zahringer,, A. J. Coyle,, P. S. DiStefano,, J. Bertin,, P. J. Sansonetti, and, D. J. Philpott. 2003. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:15841587.
26. Goodman, S. D., and, J. J. Scocca. 1988. Identification and arrangement of the DNA sequence recognized in specific transformation of Neisseria gonorrhoeae. Proc. Natl. Acad. Sci. USA 85:69826986.
27. Gray-Owen, S. D.,, C. Dehio,, A. Haude,, F. Grunert, and, T. F. Meyer. 1997a. CD66 carcinoembryonic antigens mediate interactions between Opa-expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes. EMBO J. 16:34353445.
28. Gray-Owen, S. D.,, D. R. Lorenzen,, A. Haude,, T. F. Meyer, and, C. Dehio. 1997b. Differential Opa specificities for CD66 receptors influence tissue interactions and cellular response to Neisseria gonorrhoeae. Mol. Microbiol. 26:971980.
29. Guibourdenche, M.,, M. Y. Popoff, and, J. Y. Riou. 1986. Deoxyribonucleic acid relatedness among Neisseria gonorrhoeae, N. meningitidis, N. lactamica, N. cinerea, and “Neisseria polysaccharea. Ann. Inst. Pasteur. Microbiol. 137B:177185.
30. Gupta, S., and, M. C. Maiden. 2001. Exploring the evolution of diversity in pathogen populations. Trends Microbiol. 9:181185.
31. Hermans, P. W.,, M. L. Hibberd,, R. Booy,, O. Daramola,, J. A. Hazelzet,, R. de Groot, and, M. Levin. 1999. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 354:556560.
32. Hibberd, M. L.,, M. Sumiya,, J. A. Summerfield,, R. Booy, and, M. Levin. 1999. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet 353:10491053.
33. Holmes, E. C.,, R. Urwin, and, M. C. Maiden. 1999. The influence of recombination on the population structure and evolution of the human pathogen Neisseria meningitidis. Mol. Biol. Evol. 16:741749.
34. Holst, J.,, B. Feiring,, L. M. Naess,, G. Norheim,, P. Kristiansen,, E. A. Hoiby,, K. Bryn,, P. Oster,, P. Costantino,, M. K. Taha,, J. M. Alonso,, D. A. Caugant,, E. Wedege,, I. S. Aaberge,, R. Rappuoli, and, E. Rosenqvist. 2005. The concept of “tailor-made,” protein-based, outer membrane vesicle vaccines against meningococcal disease. Vaccine 23:22022205.
35. Hubert, B.,, L. Watier,, P. Garnerin, and, S. Richardson. 1992. Meningococcal disease and influenza-like syndrome: a new approach to an old question. J. Infect. Dis. 166:542545.
36. Jacob, F. 1977. Evolution and tinkering. Science 196:11611166.
37. Johansson, L.,, A. Rytkonen,, P. Bergman,, B. Albiger,, H. Kallstrom,, T. Hokfelt,, B. Agerberth,, R. Cattaneo, and, A. B. Jonsson. 2003. CD46 in meningococcal disease. Science 301:373375.
38. Jolley, K. A.,, J. Kalmusova,, E. J. Feil,, S. Gupta,, M. Musilek,, P. Kriz, and, M. C. Maiden. 2000. Carried meningococci in the Czech Republic: a diverse recombining population. J. Clin. Microbiol. 38:44924498.
39. Kallstrom, H.,, M. K. Liszewski,, J. P. Atkinson, and, A. B. Jonsson. 1997. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 25:639647.
40. Kirchner, M.,, D. Heuer, and, T. F. Meyer. 2005. CD46–independent binding of neisserial type IV pili and the major pilus adhesin, PilC, to human epithelial cells. Infect. Immun. 73:30723082.
41. Lancellotti, M.,, A. Guiyoule,, C. Ruckly,, E. Hong,, J. M. Alonso, and, M. K. Taha. 2006. Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37/ST-11 clonal complex. Microbes Infect. 8:191196.
42. Lapeyssonnie, L. 1963. Cerebrospinal meningitis in Africa. Bull. World Health Org. 28(Suppl): 1114.
43. Lipsitch, M., and, E. R. Moxon. 1997. Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol. 5:3137.
44. Long, S. S. 2005. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine. Clin. Infect. Dis. 41:3034.
45. Maiden, M. C.,, J. A. Bygraves,, E. Feil,, G. Morelli,, J. E. Russell,, R. Urwin,, Q. Zhang,, J. Zhou,, K. Zurth,, D. A. Caugant,, I. M. Feavers,, M. Achtman, and, B. G. Spratt. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA 95:31403145.
46. Maiden, M. C. 2000. High-throughput sequencing in the population analysis of bacterial pathogens of humans. Int. J. Med. Microbiol. 290:183190.
47. Merz, A. J.,, C. A. Enns, and, M. So. 1999. Type IV pili of pathogenic Neisseriae elicit cortical plaque formation in epithelial cells. Mol. Microbiol. 32:13161332.
48. Merz, A. J., and, M. So. 1997. Attachment of piliated, Opa- and Opc- gonococci and meningococci to epithelial cells elicits cortical actin rearrangements and clustering of tyrosine-phosphorylated proteins. Infect. Immun. 65:43414349.
49. Morand, P. C.,, E. Bille,, S. Morelle,, E. Eugene,, J. L. Beretti,, M. Wolfgang,, T. F. Meyer,, M. Koomey, and, X. Nassif. 2004. Type IV pilus retraction in pathogenic Neisseria is regulated by the PilC proteins. EMBO J. 23:20092017.
50. Nassif, X.,, M. Marceau,, C. Pujol,, B. Pron,, J. L. Beretti, and, M. K. Taha. 1997. Type-4 pili and meningococcal adhesiveness. Gene 192:149153.
51. Nicolas, P.,, G. Norheim,, E. Garnotel,, S. Djibo, and, D. A. Caugant. 2005. Molecular epidemiology of neisseria meningitidis isolated in the African meningitis belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. J. Clin. Microbiol. 43:51295135.
52. Njanpop-Lafourcade, B. M.,, I. Parent du Chatelet,, O. Sanou,, J. M. Alonso, and, M. K. Taha. 2005. The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso. Microbes Infect. 7:645649.
53. Noah, N., and, B. Henderson. 2001. Surveillance of Bacterial Meningitis in Europe 1999–2000. PHLS, London, United Kingdom.
54. Otto, S. P., and, S. L. Nuismer. 2004. Species interactions and the evolution of sex. Science 304:10181020.
55. Parent du Chatelet, I.,, Y. Traore,, B. D. Gessner,, A. Antignac,, B. Naccro,, B. M. Njanpop-Lafourcade,, M. S. Ouedraogo,, S. R. Tiendrebeogo,, E. Varon, and, M. K. Taha. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin. Infect. Dis. 40:1725.
56. Perkins-Balding, D.,, M. Ratliff-Griffin, and, I. Stojiljkovic. 2004. Iron transport systems in Neisseria meningitidis. Microbiol. Mol. Biol. Rev. 68:154171.
57. Perrocheau, A.,, M. Taha, and, D. Levy-Bruhl. 2005. Epidemiology of invasive meningococcal disease in France in 2003. Eurosurveillance 10:238241.
58. Post, D. M.,, N. J. Phillips,, J. Q. Shao,, D. D. Entz,, B. W. Gibson, and, M. A. Apicella. 2002. Intracellular survival of Neisseria gonorrhoeae in male urethral epithelial cells: importance of a hexaacyl lipid A. Infect. Immun. 70:909920.
59. Pujol, C.,, E. Eugene,, L. de Saint Martin, and, X. Nassif. 1997. Interaction of Neisseria meningitidis with a polarized monolayer of epithelial cells. Infect. Immun. 65:48364842.
60. Ram, S.,, F. G. Mackinnon,, S. Gulati,, D. P. McQuillen,, U. Vogel,, M. Frosch,, C. Elkins,, H. K. Guttormsen,, L. M. Wetzler,, M. Oppermann,, M. K. Pangburn, and, P. A. Rice. 1999. The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol. Immunol. 36:915928.
61. Ramsay, M. E.,, N. Andrews,, E. B. Kaczmarski, and, E. Miller. 2001. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357:195196.
62. Rosenstein, N. E.,, B. A. Perkins,, D. S. Stephens,, L. Lefkowitz,, M. L. Cartter,, R. Danila,, P. Cieslak,, K. A. Shutt,, T. Popovic,, A. Schuchat,, L. H. Harrison, and, A. L. Reingold. 1999. The changing epidemiology of meningococcal disease in the United States, 1992–1996. J. Infect. Dis. 180:18941901.
63. Sierra, G. V.,, H. C. Campa,, N. M. Varcacel,, I. L. Garcia,, P. L. Izquierdo,, P. F. Sotolongo,, G. V. Casanueva,, C. O. Rico,, C. R. Rodriguez, and, M. H. Terry. 1991. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14:195207 discussion 20810].
64. Smith, J. M.,, C. G. Dowson, and, B. G. Spratt. 1991. Localized sex in bacteria. Nature 349:2931.
65. Sparling, P. F. 2002. A plethora of host factors that determine the outcome of meningococcal infection. Am. J. Med. 112:7274.
66. Steeghs, L.,, R. den Hartog,, A. den Boer,, B. Zomer,, P. Roholl, and, P. van der Ley. 1998. Meningitis bacterium is viable without endotoxin. Nature 392:449450.
67. Steeghs, L.,, M. P. Jennings,, J. T. Poolman, and, P. van der Ley. 1997. Isolation and characterization of the Neisseria meningitidis lpxD-fabZ-lpxA gene cluster involved in lipid A biosynthesis. Gene 190:263270.
68. Taha, M. K.,, M. Achtman,, J. M. Alonso,, B. Greenwood,, M. Ramsay,, A. Fox,, S. Gray, and, E. Kaczmarski. 2000. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356:2159.
69. Taha, M. K.,, J. M. Alonso,, M. Cafferkey,, D. A. Caugant,, S. C. Clarke,, M. A. Diggle,, A. Fox,, M. Frosch,, S. J. Gray,, M. Guiver,, S. Heuberger,, J. Kalmusova,, K. Kesanopoulos,, A. M. Klem,, P. Kriz,, J. Marsh,, P. Mölling,, K. Murphy,, P. Olcén,, O. Sanou,, G. Tzanakaki, and, U. Vogel. 2005. Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis. J. Clin. Microbiol. 43:144149.
70. Taha, M. K.,, A. E. Deghmane,, A. Antignac,, M. L. Zarantonelli,, M. Larribe, and, J. M. Alonso. 2002a. The duality of virulence and transmissibility in Neisseria meningitidis. Trends Microbiol. 10:376382.
71. Taha, M. K., and, C. Marchal. 1990. Conservation of Neisseria gonorrhoeae pilus expression regulatory genes pilA and pilB in the genus Neisseria. Infect. Immun. 58:41454158.
72. Taha, M. K.,, I. Parent Du Chatelet,, M. Schlumberger,, I. Sanou,, S. Djibo,, F. de Chabalier, and, J. M. Alonso. 2002b. Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J. Clin. Microbiol. 40:10831084.
73. Taha, M. K.,, M. L. Zarantonelli,, J. M. Alonso,, L. M. Naess,, J. Holst,, B. Feiring, and, E. Rosenqvist. 2007. Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks. Vaccine 25:25372538.
74. Tappero, J. W.,, R. Lagos,, A. M. Ballesteros,, B. Plikaytis,, D. Williams,, J. Dykes,, L. L. Gheesling,, G. M. Carlone,, E. A. Hoiby,, J. Holst,, H. Nokleby,, E. Rosenqvist,, G. Sierra,, C. Campa,, F. Sotolongo,, J. Vega,, J. Garcia,, P. Herrera,, J. T. Poolman, and, B. A. Perkins. 1999. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA 281:15201527.
75. Touqui, L.,, M. Paya,, F. Thouron,, A. Guiyoule,, M. L. Zarantonelli,, D. Leduc,, Y. Wu,, M. K. Taha, and, J. M. Alonso. 2005. Neisseria meningitidis pili induce type-IIA phospholipase A2 expression in alveolar macrophages. FEBS Lett. 579:49234927.
76. Trees, D. L.,, A. L. Sandul,, S. W. Neal,, H. Higa, and, J. S. Knapp. 2001. Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991–1999. Sex. Transm. Dis. 28:309314.
77. Trotter, C.,, S. Samuelsson,, A. Perrocheau,, S. de Greeff,, H. de Melker,, S. Heuberger, and, M. Ramsay. 2005. Ascertainment of meningococcal disease in Europe. Eurosurveillance 10:247250.
78. Trotter, C. L.,, A. J. Fox,, M. E. Ramsay,, F. Sadler,, S. J. Gray,, R. Mallard, and, E. B. Kaczmarski. 2002a. Fatal outcome from meningococcal disease—an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. J. Med. Microbiol. 51:855860.
79. Trotter, C. L.,, M. E. Ramsay, and, E. B. Kaczmarski. 2002b. Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign. Commun. Dis. Public Health 5:220225.
80. van der Ley, P., and, L. Steeghs. 2003. Lessons from an LPS-deficient Neisseria meningitidis mutant. J. Endotoxin. Res. 9:124128.
81. van Deuren, M.,, P. Brandtzaeg, and, J. W. van der Meer. 2000. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13:144166.
82. van Deuren, M.,, J. van der Ven-Jongekrijg,, A. K. Bartelink,, R. van Dalen,, R. W. Sauerwein, and, J. W. van der Meer. 1995. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J. Infect. Dis. 172:433439.
83. van Putten, J. P.,, S. F. Hayes, and, T. D. Duensing. 1997. Natural proteoglycan receptor analogs determine the dynamics of Opa adhesin-mediated gonococcal infection of Chang epithelial cells. Infect. Immun. 65:50285034.
84. Vienne, P.,, M. Ducos-Galand,, A. Guiyoule,, R. Pires,, D. Giorgini,, M. K. Taha, and, J. M. Alonso. 2003. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin. Infect. Dis. 37:16391642.
85. Virji, M.,, S. M. Watt,, S. Barker,, K. Makepeace, and, R. Doyonnas. 1996. The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol. Microbiol. 22:929939.
86. Vogel, U., and, M. Frosch. 1999. Mechanisms of neisserial serum resistance. Mol. Microbiol. 32:11331139.
87. Waage, A.,, A. Halstensen, and, T. Espevik. 1987. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355357.
88. Winther-Larsen, H. C.,, F. T. Hegge,, M. Wolfgang,, S. F. Hayes,, J. P. van Putten, and, M. Koomey. Neisseria gonorrhoeae PilV, a type IV pilus-associated protein essential to human epithelial cell adherence. Proc. Natl. Acad. Sci. USA 98:1527615281.
89. Winther-Larsen, H. C.,, M. Wolfgang,, S. Dunham,, J. P. van Putten,, D. Dorward,, C. Lovold,, F. E. Aas, and, M. Koomey. 2005. A conserved set of pilin-like molecules controls type IV pilus dynamics and organelle-associated functions in Neisseria gonorrhoeae. Mol. Microbiol. 56:903917.
90. Woods, C. R. 2005. Gonococcal infections in neonates and young children. Semin. Pediatr. Infect. Dis. 16:258270.
91. Yazdankhah, S. P., and, D. A. Caugant. 2004. Neisseria meningitidis: an overview of the carriage state. J. Med. Microbiol. 53:821832.
92. Yazdankhah, S. P.,, P. Kriz,, G. Tzanakaki,, J. Kremastinou,, J. Kalmusova,, M. Musilek,, T. Alvestad,, K. A. Jolley,, D. J. Wilson,, N. D. McCarthy,, D. A. Caugant, and, M. C. Maiden. 2004. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J. Clin. Microbiol. 42:51465153.
93. Zarantonelli, M. L.,, J. P. Carlier,, J. M. Alonso, and, M. K. Taha. 2003. Insertional inactivation of the lpxA gene involved in the biosynthesis of lipid A in Neisseria meningitidis resulted in lpxA/lpxA::aph-3’ heterodiploids. FEMS Microbiol. Lett. 226:5156.
94. Zhu, Z.,, T. P. Atkinson,, K. T. Hovanky,, S. B. Boppana,, Y. L. Dai,, P. Densen,, R. C. Go,, J. S. Jablecki, and, J. E. Volanakis. 2000. High prevalence of complement component C6 deficiency among African-Americans in the south-eastern USA. Clin. Exp. Immunol. 119:305310.
95. Zughaier, S. M.,, Y. L. Tzeng,, S. M. Zimmer,, A. Datta,, R. W. Carlson, and, D. S. Stephens. 2004. Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect. Immun. 72:371380.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error